**Core tip:** Schizophrenia is associated with impairment in executive function, verbal memory, verbal fluency and attention. Neuropsychological tests are associated with structural and functional brain alterations. This case report is an example of the potential correlation between clinical symptoms (*e.g*., cognitive impairment) and brain changes. These data may help in the prediction of possible outcome of schizophrenia patients.

INTRODUCTION
============

A number of data would indicate schizophrenia as a progressive neurodegenerative disorder\[[@B1]\] whose outcome is influenced by many biological and clinical factors\[[@B2]\]. Of note, recent literature shows that neuropsychological deficits at onset may predict the clinical course of illness\[[@B3]\] being often associated with frontal and parietal lobe dysfunctions\[[@B4]-[@B6]\]. Moreover, a recent trial found that brain abnormalities of schizophrenic patients change according to age at onset. In particular, early onset patients show parietal abnormalities, while adult onset patients exhibit frontal and temporal ones\[[@B7]\].

To our knowledge there are few studies\[[@B8]-[@B10]\] associating cognitive frontal and parietal deficits with structural \[magnetic resonance (MR)\] and functional neuroimaging \[positron emission tomography (PET)\] and the anatomical and functional relationships underlying this deficit remain to be elucidated. Dysconnectivity, a failure in functional integration, is considered a key mechanism in the pathophysiology of cognitive impairments (in particular working memory performance) in individuals with schizophrenia\[[@B11]\].

The present paper deals with a recent diagnosed schizophrenic patient showing frontal and parietal lobe MR/PET abnormalities clinically associated with deficits in the corresponding cognitive domains.

CASE REPORT
===========

The patient was a 19-year-old man admitted in our department. The patient showed nor psychiatric comorbidity with an Axis I disorder neither personality disorders. A neurological exam, performed by a neurologist, was negative. Diagnosis of undifferentiated schizophrenia and exclusion of comorbid conditions were assessed through the administration of semi-structured interviews based on DSM-IV criteria (SCID I and II). Patient had family history for psychiatric disorders: The father was an alcohol abuser, one schizophrenic uncle (father's brother) committed suicide and the grandmother in mother line was affected by bipolar disorder. At the admission in our ward the patient was drug-naïve and showed persecutory delusion, auditory hallucinations, thought/behavioural disorganization and a duration of untreated psychosis of 9 mo\[[@B12]\]. Baseline score at Positive and Negative Syndrome Scale\[[@B13]\] was 84, while baseline score at Brief Psychiatric Rating Scale was 55\[[@B14]\]. In the first days of admission patient underwent to neuropsychological tests, cerebral MR and cerebral PET.

A neuropsychological battery was designed to encompass the areas believed to be affected by Schizophrenia\[[@B15]\]. Results and standard scores are summarized in Table [1](#T1){ref-type="table"}. Patient's neurocognitive performances provided evidence for impairment in the following domains: Executive function (Cognitive Estimation, Verbal fluency, Trail Making Test), verbal memory, verbal ability (Boston Naming Test, phonemic Verbal Fluency) and attention (Visual Search, Trail Making Test). In addition, the patient failed in two Wechsler Adult Intelligence Scale\[[@B16]\] subscales: Verbal Comprehension Index and Perceptual Organization Index.

###### 

Neuropsychological results

  **Test**                                        **Patient score**                                       **Normal value**   **Result**         **Z-score**
  ----------------------------------------------- ------------------------------------------------------- ------------------ ------------------ -------------
  Mini-mental state examination                   27.19                                                   24-29.19           Normal             0.45
  Executive functions: Tower of London            25                                                      20-36              Normal             -0.75
  Frontal assessment battery                      15.98                                                   13.5-17.3          Normal             -0.95
  Cognitive estimation task                       19.97                                                   0-18               Failed             2.43
  Bizarreness                                     6                                                       0-4                Failed             4
  Problem solving: Raven's progressive matrices   29.05                                                   18.6-33.05         Normal             0.89
  Assessment of cognitive impairment in memory                                                                                                  
  Verbal memory and learning                                                                                                                    
  Digit Span                                      5.75                                                    3.75-8.75          Normal             -0.4
  Verbal Learning                                 10.50                                                   6.50-21.50         Normal             -0.93
  Recall of prose: Immediate and after 10 min     3.50                                                    8.00-27.50         Failed             -2.92
  Spatial short-term memory (Corsi test)          4.50                                                    3.50-8.50          Normal             -1.20
  Attention and speed information processing                                                                                                    
  Trail making test                                                                                                                             
  Part A                                          33                                                      \< 93 s            Normal             
  Part B, dual task                               161                                                     \< 282 s           Normal             
  Part B-A                                        128                                                     \< 186 s           Borderline score   -1.36
  Visual search                                   34.25                                                   31-51.25           Borderline score   
  Verbal fluency                                                                                                                                
  Phonemic                                        23                                                      17-59              Borderline score   -1.43
  Categories                                      32                                                      25-58              Normal             -1.15
  Language                                                                                                                                      
  Boston naming test                              31                                                      43-60              Failed             -4.82
  Token test                                      32                                                      29-36              Normal             -0.29
  Wechsler adult intelligence scale-revised       General IQ = 75 (verbal IQ = 81; performance IQ = 74)   80-120             Borderline score   -2.50
                                                  VCI = 5.5; POI = 6.25                                                                         

The standard scores, reported in the second column, are calculated considering a normal population. Our patient's scores, adjusted for age, sex and education are shown in the first column next to each test. A score is considered pathological when the score is present less than 5% of the normal population. Sometimes normal scores are considered pathological due to the clinical condition and the global performance. VCI: Verbal comprehension index; POI: Perceptual organization index.

MR was performed using a circular polarized head coil and included Turbo Spin-Echo T1-weighted sequences, T2-weighted sequences and FLAIR. Imaging in three planes was performed using 5-mm slice thickness. MR revealed normal-sized ventricles, normal-sized subarachnoidal spaces, no abnormalities in gray matter, but bilaterally soft hyper-intensities in superior parietal lobe\[[@B4]\] periventricular white matter.

Fluorodeoxyglucose (FDG) was injected in condition of rest and fasting and after 30 min three-dimensional scan was performed. The images were compared to a cohort of normal ones. Fluoro-D-Glucose PET (Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}) showed glucose frontal and parietal lobes hypo-metabolism bilaterally. No further abnormalities in FDG distribution were observed.

![D-glucose (fluorodeoxyglucose) positron emission tomography, transversal sections. Pointer 1 displays the frontal lobe hypo-metabolism; pointer 2 displays the parietal lobe hypo-metabolism.](WJP-7-128-g001){#F1}

![Fluoro-D-glucose (fluorodeoxyglucose) positron emission tomography, coronal sections. Pointer 1 displays the frontal lobe hypo-metabolism; Pointer 2 displays the parietal lobe hypo-metabolism.](WJP-7-128-g002){#F2}

MR and PET were performed by neuroradiologists collaborating within our department.

Of note, neuropsychological results are consistent with outlined MR abnormalities and PET images (fronto-parietal abnormalities)\[[@B17]\].

DISCUSSION
==========

The present case report confirms data from literature of early cognitive deficits in the course of schizophrenia\[[@B18],[@B19]\] and neuroimaging parietal abnormalities in early onset schizophrenic patients\[[@B7],[@B20],[@B21]\]. In addition, the correspondence between cognitive deficits and morphological/functional brain alterations\[[@B22]\] contributes to clarify the influence of brain changes in schizophrenia clinical presentation as well as to support the hypothesis of schizophrenia as a neurodegenerative disorder\[[@B23],[@B24]\]. Recent trials found that brain abnormalities are more severe in patients with a longer duration of illness\[[@B25]-[@B27]\], novel antipsychotics are promising molecules for their efficacy in stopping the neurodegenerative process\[[@B28],[@B29]\]. In this context cognitive and neuroimaging follow-up of our case can be useful to discriminate if neurodegenerative process of schizophrenia progresses in the course of illness or it is specific of early stages\[[@B24],[@B30],[@B31]\]. Finally, it would be important in the future to define the role of neuroimaging abnormalities in influencing outcome. MR and PET could be useful tools to make diagnosis and to predict long-term course of schizophrenic illness.

COMMENTS
========

Case characteristics
--------------------

A 19-year-old male patient with severe schizophrenia presentation.

Clinical diagnosis
------------------

Patient was hospitalized because of prominent persecutory delusion, auditory hallucinations, aggressiveness and thought/behavioural disorganization.

Differential diagnosis
----------------------

Bipolar disorder, substance use disorder.

Laboratory diagnosis
--------------------

Routine blood tests were resulted within normal limits.

Imaging diagnosis
-----------------

At magnetic resonance imaging bilaterally soft hyper-intensities in superior parietal lobe periventricular white matter were detected, while positron emission tomography showed glucose parietal lobes hypo-metabolism bilaterally.

Pathological diagnosis
----------------------

Schizophrenia, acute episode.

Treatment
---------

Ziprasidone 80 mg × 2 and Gabapentin 300 mg × 3.

Related reports
---------------

Severe cognitive impairment as showed by neuropsychological tests.

Term explanation
----------------

Dysconnectivity means abnormal functional integration among brain regions resulting in impaired modulation of neurotransmitters.

Experiences and lessons
-----------------------

It is important to perform imaging evaluation and neuropsychological tests to better define long-term outcome of schizophrenia patients.

Peer-review
-----------

This case report is novel and well designed.
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